Log In
Print this Print this

ranirestat (AS-3201)

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionInhibitor of aldose reductase
Molecular Target Aldose reductase
Mechanism of ActionAldose reductase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationNeuropathy
Indication DetailsTreat diabetic neuropathy
Regulatory Designation
PartnerEisai Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today